Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Kewaunee Scientific posts record $282 million revenue, outlines fiscal 2027 investment plans

Kewaunee Scientific reported record fiscal 2026 revenue of $282 million and EBITDA of $22.4 million, driven by a full year of NuAire results and strong Lab Products Group sales. The company reduced long-term debt by about $20 million, repaid the NuAire seller note, and saw consolidated backlog fall to $165.9 million after major international project completions. For fiscal 2027 Kewaunee plans investments in product innovation, manufacturing capacity and efficiency, global commercial expansion and disciplined acquisitions while upgrading corporate infrastructure and compliance. » More on finance.yahoo.com
Kewaunee Scientific appoints J. Jette Campbell to board of directors

Kewaunee Scientific has appointed J. Jette Campbell, CPA, to its board of directors effective September 10, 2025. Campbell brings leadership experience from PepsiCo, Frito-Lay and Griffin, and served as a partner at Carl Marks Advisors. The company highlighted Campbell’s role in supporting accelerated organic and inorganic growth; revenue in the last twelve months rose 18% with a gross margin of 29%. Kewaunee also reported strong quarterly results, with adjusted EPS of $1.95 and revenue up 36.1% to $77.15 million, and announced the acquisition of Nu Aire. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2019, KEWAUN.SCIENTIFIC DL2,50 has already paid €0.51 in dividends. The last payout was in September 2019.

Financials

In the last quarter, KEWAUN.SCIENTIFIC DL2,50 had revenue of €57.49m and net profit of €1.48m

(EUR)	July 2026	YoY
Revenue	57.49m	7.65%
Gross profit	17.02m	7.09%
Net profit	1.48m	45.39%
EBITDA	4.12m	27.96%

Fundamentals

Metric	Value
Market capitalization	€86.22m
Number of shares	2.9m
52-week high/low	€38.66 - €28.53
Dividends	No
Beta	0.76
P/E ratio	11.68
PEG ratio	-0.35
P/B ratio	1.28
P/S ratio	0.35

Company profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

Name	KEWAUN.SCIENTIFIC DL2,50
CEO	Thomas David Hull
Headquarters	Statesville, nc USA
Website	kewaunee.com
Sector	Health Care
Industry	Health Care Equipment & Supplies
IPO	17/03/1980
Employees	1,231